Apolipoprotein E and Alzheimer disease.

AUTOR(ES)

Strittmatter, W J

RESUMO

Inheritance of specific apolipoprotein E (apoE) alleles determines, in large part, the risk and mean age of onset of late-onset familial and sporadic Alzheimer disease. The mechanism by which the apoE isoforms differentially contribute to disease expression is, however, unknown. Isoform-specific differences have been identified in the binding of apoE to the microtubule-associated protein tau, which forms the paired helical filament and neurofibrillary tangles, and to amyloid beta peptide, a major component of the neuritic plaque. These and other isoform-specific interactions of apoE give rise to testable hypotheses for the mechanism(s) of pathogenesis of Alzheimer disease. An unresolved issue of increasing importance is the relationship between the structural pathological lesions and the cellular pathogenesis responsible for the clinical disease phenotype, progressive dementia. The identification of apoE in the cytoplasm of human neurons and the characterization of isoform-specific binding of apoE to the microtubule-associated proteins tau and MAP-2 present the possibility that apoE may affect microtubule function in the Alzheimer brain.

Documentos Relacionados

• Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.
• Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.
• Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease.
• Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
• Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.